Knygos.lt klubas Knygos.lt nariams
297,21 €
-30%
Įprastai
424,59 €
Current Topics in Nonclinical Drug Development
Current Topics in Nonclinical Drug Development
Knygos.lt klubas Knygos.lt nariams
297,21 €
-30%
Įprastai
424,59 €
  • Planuojame turėti už 136 d.
This third volume in the series focuses on such germane issues as the weight of evidence approach, the 3Rs, (Replacement, Reduction, and Refinement) personalized drug therapies, and oncology therapeutics, among others. Volumes in this series are aimed at toxicologists and toxicologic pathologists involved in drug development. Volumes in the Current Topics in Nonclinical Drug Development series are aimed at toxicologists, toxicologic pathologists, regulators, and study directors, dealing with is…
  • Leidėjas:
  • Metai: 2026
  • Puslapiai: 328
  • ISBN-10: 1032803509
  • ISBN-13: 9781032803500
  • Kalba: Anglų

Current Topics in Nonclinical Drug Development (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Įvertinimų nėra.
Įvertink ir tu! Visi atsiliepimai

Aprašymas

This third volume in the series focuses on such germane issues as the weight of evidence approach, the 3Rs, (Replacement, Reduction, and Refinement) personalized drug therapies, and oncology therapeutics, among others. Volumes in this series are aimed at toxicologists and toxicologic pathologists involved in drug development. Volumes in the Current Topics in Nonclinical Drug Development series are aimed at toxicologists, toxicologic pathologists, regulators, and study directors, dealing with issues in study design, evaluation of findings, and presentation of data. In addition, the series will serve as an aid to academicians and graduate students studying nonclinical drug development.

Key Features:

  • Explores the critical issues and current topics important in nonclinical drug development
  • Deals with day-to-day issues in study design, evaluation of findings, and presentation of data
  • Aids academicians and graduate students pursuing research related to nonclinical drug development
  • Delves into both the art and science of nonclinical drug development and its impact on translational medicine and human safety
Knygos.lt klubas
Knygos.lt nariams
297,21 €
-30%
Įprastai
424,59 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 4,25 Knygų Eurų!?
Planuojame turėti už 136 d.
Įsigykite dovanų kuponą
Daugiau
  • Leidėjas:
  • Metai: 2026
  • Puslapiai: 328
  • ISBN-10: 1032803509
  • ISBN-13: 9781032803500
  • Kalba: Anglų

This third volume in the series focuses on such germane issues as the weight of evidence approach, the 3Rs, (Replacement, Reduction, and Refinement) personalized drug therapies, and oncology therapeutics, among others. Volumes in this series are aimed at toxicologists and toxicologic pathologists involved in drug development. Volumes in the Current Topics in Nonclinical Drug Development series are aimed at toxicologists, toxicologic pathologists, regulators, and study directors, dealing with issues in study design, evaluation of findings, and presentation of data. In addition, the series will serve as an aid to academicians and graduate students studying nonclinical drug development.

Key Features:

  • Explores the critical issues and current topics important in nonclinical drug development
  • Deals with day-to-day issues in study design, evaluation of findings, and presentation of data
  • Aids academicians and graduate students pursuing research related to nonclinical drug development
  • Delves into both the art and science of nonclinical drug development and its impact on translational medicine and human safety

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)
Knygos.lt komentarų taisyklės
[{"option":"222","probability":1,"style":{"backgroundColor":"#ffffff"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba631ba76d1782294065.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"221","probability":1.3,"style":{"backgroundColor":"#e1032e"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba61ea9f381782294046.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"220","probability":1.6,"style":{"backgroundColor":"#ffffff"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba60167d251782294017.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"219","probability":1.5,"style":{"backgroundColor":"#e2022e"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba5ea1c47d1782293994.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"218","probability":1.5,"style":{"backgroundColor":"#ffffff"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba5d38b4a21782293971.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"217","probability":1.6,"style":{"backgroundColor":"#e3022e"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba5b981b7a1782293945.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"216","probability":1.4,"style":{"backgroundColor":"#ffffff"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba58b535551782293899.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"215","probability":0.1,"style":{"backgroundColor":"#ffe01a"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba53a6496f1782293818.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}}]